News Enemsa Pharma Secures Rights from UChicago to Develop Novel Therapeutic Enemsa Pharma has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment of demyelinating diseases.
News UChicago Grants InFlectis BioScience Exclusive Rights to a Potential New Class of Therapies for Neuromuscular Diseases The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has granted InFlectis BioScience rights to use a patented family of small molecules for the treatment of neuromuscular diseases. Per the...
News Microbiome Research Symposium Highlights Potential of Research-backed Startups to Impact Patient Care Scientists, faculty, entrepreneurs and researchers gathered at UChicago’s Microbiome Research Symposium on April 16 at the Logan Center for the Arts.
News Polsky Center Fall 2021 I-Corps Teams Tackle Unmet Medical Needs, Data Transparency, and Other Challenges The Polsky Center’s fall 2021 I-Corps cohort is developing diagnostics, novel therapeutics, innovative devices, new materials, and other technologies across various industries. The Polsky I-Corps program is a 7-week highly-experiential...
News AI, Life Sciences, Quantum Tech to Get Boost as Part of the Compass Accelerator’s Latest Cohort The Polsky Center for Entrepreneurship and Innovation is pleased to announce that six teams have been selected for the latest cohort of Compass, a deep tech accelerator program for University...
News UChicago Microbiome Startups Come Together Under New Company to Amplify Results Two University of Chicago startups are now operating under a parent company, 32 Biosciences – with a shared goal to revolutionize health care through advances in microbiome science. The name...
